BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20193111)

  • 1. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
    He D; Xiao L; Chen JN; Liang Q; Shao CK
    Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.
    Wang Y; Luo B; Yan LP; Huang BH; Zhao P
    World J Gastroenterol; 2005 Jun; 11(21):3234-9. PubMed ID: 15929173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
    Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
    Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2001 Jan; 127(1):20-6. PubMed ID: 11206267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma.
    Kuang X; Sun L; Liu S; Zhao Z; Zhao D; Liu S; Luo B
    Virol Sin; 2016 Aug; 31(4):306-13. PubMed ID: 27535066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
    Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
    Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
    Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
    World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
    Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
    J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
    Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
    Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma.
    Gong LP; Chen JN; Xiao L; He Q; Feng ZY; Zhang ZG; Liu JP; Wei HB; Shao CK
    Hum Pathol; 2019 Mar; 85():82-91. PubMed ID: 30448221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the expression of P53 protein and P21WAF1 protein in the gastric carcinoma tissues associated with Epstein-Barr virus (EBV) infections].
    Qian J; Li DQ; Zhong F; Li ZX; Lu LC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):1-3. PubMed ID: 16642206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
    Xu LN; Zou SQ; Wang JM
    World J Gastroenterol; 2005 Jun; 11(24):3719-23. PubMed ID: 15968727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer.
    Ohno S; Tachibana M; Shibakita M; Dhar DK; Yoshimura H; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Ann Surg Oncol; 2000 Dec; 7(10):750-7. PubMed ID: 11129423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
    Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
    Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
    Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.